The Caveolin-1 Connection to Cell Death and Survival
Journal:
Current Molecular Medicine
Volume:
13
Page:
266-281
Author(s):
A. F. G. Quest, L. Lobos-Gonzalez, S. Nunez, C. Sanhueza, J.-G. Fernandez, A. Aguirre, D. Rodriguez, L. Leyton and V. Torres
A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein
Journal:
Current Molecular Medicine
Volume:
13
Page:
305-316
Author(s):
B. Hernaez, M. Cabezas, R. Munoz-Moreno, I. Galindo, M. A. Cuesta-Geijo and C. Alonso
Recent Trends in the Pharmacological Activity of Isoprenyl Phenolics
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
272-279
Author(s):
M. Marin and S. Manez
Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Journal:
Current Rheumatology Reviews
Volume:
8
Page:
209-226
Author(s):
Toshio Tanaka, Atsushi Ogata, Yoshihito Shima, Masashi Narazaki, Atsushi Kumanogoh and Tadamitsu Kishimoto
Pharmacotherapy in Systemic Lupus Erythematosus
Journal:
Current Rheumatology Reviews
Volume:
8
Page:
166-179
Author(s):
Layla E. Borham
Current Status and Future Prospects for Research on Tyrosine Sulfation
Journal:
Current Pharmaceutical Biotechnology
Volume:
13
Page:
2632-2641
Author(s):
Nobuya Sasaki
HtrA Protease Family as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
977-1009
Author(s):
Joanna Skorko-Glonek, Dorota Zurawa-Janicka, Tomasz Koper, Miroslaw Jarzab, Donata Figaj, Przemyslaw Glaza and Barbara Lipinska
Viral Proteases as Targets for Drug Design
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
1126-1153
Author(s):
Marcin Skorenski and Marcin Sienczyk
Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
108-122
Author(s):
A. Adan-Gokbulut, M. Kartal-Yandim, G. Iskender and Y. Baran
Thermosensitive Polymeric Hydrogels As Drug Delivery Systems
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
79-94
Author(s):
C. Gong, T. Qi, X. Wei, Y. Qu, Q. Wu, F. Luo and Z. Qian